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NEUROTRANSMITTERS AND NEUROMODULATORS 
FELIX A. STEINER 
Department of Experimental Medicine, F. Hoffmann-La Roche Co. Ltd., Basel, and Institute for Brain 
Research, University of Zurich, Switzerland 
In the central nervous system, besides the neurotransmitters, the occurrence of substances which 
modify neuronal excitability has been proposed. Since their effect is a matter of modulating 
neuronal responsiveness, these substances may be called neuromodulators. 
Examples of neurotransmitters or putative neurotransmitters in the central nervous system 
are acetylcholine, noradrenaline, dopamine, and aminoacids such as GABA, glycine, and L-glu-
tamic acid. Under certain conditions, some of these {acetylcholine, L-glutamic acid, and GABA), 
as well as hormones and polypeptides {e.g., releasing factors) are considered to act as neuro-
modulators. 
In spite of the relative inaccessibility and great complexity of synapses in the central nerv-
ous system, important aspects of their anatomy (Pappas and Purpura 1972), biochemistry 
(Baldessarini and Karobath 1973, Smellie 1972), pharmacology (Phillis 1970), and physiology 
(Eccles 1964, McLennan 1970, Steiner 1971) have been elucidated in recent years. Among 
the many experimental techniques used in their study, the method of microelectrophoresis 
(Curtis 1964, Steiner 1971) has proved particularly efficient, because it has allowed to test 
the action of neurotransmitters (or of transmitter candidates) at the level of the single neurone. 
Neurotransmitters are substances which are released from nerve endings following de-
polarization by invading action potentials, diffuse across the synaptic cleft and interact with 
specific receptors situated on the postsynaptic membrane. Depending on the nature of the 
transmitter and/or the nature of the receptor, the transmitter will either increase the Na+ 
conductance of the postsynaptic membrane (thereby producing excitatory postsynaptic 
potentials, EPSPs) or the CI- conductance of the postsynaptic membrane (thus producing 
inhibitory postsynaptic potentials, IPSPs). The net sum of spatial and temporal summation 
of EPSPs and IPSPs determines whether or not the postsynaptic membrane gets sufficiently 
depolarized to generate a propagated action potential or to get hyperpolarized so as not to 
respond to further depolarizing stimuli. Depolarization is therefore consistent with excitation 
and hyperpolarization with inhibition of the postsynaptic element. The process of chemical trans-
mission across a synapse (Table) is fast (of the order of msec), and the action of the liberated 
transmitter is terminated equally promptly either by enzymatic hydrolysis within the synaptic 
cleft (as in the case of acetylcholine) or by reuptake into the presynaptic terminal (as in the 
case of monoamines). 
In order to qualify as a transmitter, a substance must be shown to be present in nerve ter-
minals, to be released upon orthodromic nerve stimulation (criterion of chemical identity), 
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TABLE 
BIOPHYSICS AND BIOCHEMISTRY OF TRANSMITTER IN SYNAPSES 
Presynaptic Synaptic cleft Postsynaptic 
Diffusion »- 1. Receptor site 
(binding) 
I 
2. Permeability change 
in membrane 
I 
Diffusion 3. Inactivation 
a) enzyme 
away b) uptake 
and the (enzymatic) machinery for its synthesis and its removal must be demonstrable close 
to the synapse. Likewise, the same substance added to the system from without must be 
shown to exert identical physiological effects (criterion of physiological identity) and to react 
in an identical way to pharmacological manipulations (criterion of pharmacological iden-
tity). For most neurotransmitters it is at present impossible to satisfy all these requirements 
at any given central synapse; in fact, the only instance where all these criteria have been met 
more or less pertains to the action of acetylcholine (ACh) on the so-called Renshaw cells of 
the spinal cord (Curtis 1963). In all other cases, it is customary to label likely candidates as 
" putative " neurotransmitters. Their list, which is growing steadily, at present includes 
acetylcholine, monoamines such as noradrenaline, dopamine, 5-hydroxytryptamine, hista-
mine, and several aminoacids some of which (acidic aminoacids: glutamic acid, aspartic acid) 
are generally excitatory, whereas others (neutral aminoacids: GABA, glycine) have hyper-
polarizing effects and therefore inhibit the postsynaptic neuronal element. 
All of the above-mentioned substances have been tested by microelectrophoresis (see 
McLennan 1970, Phillis 1970, Steiner 1971) and the distribution of susceptible neurones and 
the direction of their response have been recorded in many brain areas. In this way it has 
been found that aminoacids such as glutamic acid or GABA elicit a rapid and stereotype 
response from practically all neurones (excitation in the case of glutamic acid and inhibition 
in the case of GABA), but that only a certain proportion of neurones respond to acetyl-
choline or to monoamines and that the direction of the drug effect and its time course may 
vary between cell populations (Steiner 1971). In addition, it has been observed that substanees 
which are not normally considered as putative neurotransmitters can also, in certain cases, 
affect the rate of discharge of single neurones if delivered by microelectrophoresis and change 
1. Biosynthesis 
(and degradation) 
I 
2. Storage (vesicles) 
3. Release 
4. Reuptake 
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the responsiveness of neurones to neurotransmitters, either in the sense of an enhancement 
or of a diminuition of the response. From this latter observation the important concept of 
neuromodulation has been derived (Florey 1967, Steiner 1971). The list of presumed neuro-
modulators besides acetylcholine and aminoacids includes hormones [dexamethasone cor-
ticosterone, triiodothyronine (T3), L-thyroxine (T4), ACTH, TRF (thryrotropin releasing 
factor)], prostaglandines, cAMP, substance P, and adenosine (Florey 1967, Steiner 1971 
and 1973). 
These substances are probably not synthesized within the presynaptic element and there-
fore do not meet one of the key criteria for neurotransmitters, yet they exhibit readily 
demonstrable effects on synaptic transmission. Some examples will be given below. Neuro-
modulators may act either by influencing the reusability of neurotransmitters from pre-
synaptic terminals or the interaction of the transmitter with the postsynaptic receptor (or 
both), and thus may alter the net result of neurotransmitter action in a quantitative (but 
not in a qualitative) sense. Neuromodulators also could act directly on the postsynaptic 
membrane. 
\ 
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Fig. 1. Activation of neurones in the lateral geniculate body by visual stimulation (i) 
(A) Control, after systemic administration of phenobarbital (2.5 mg/Kg i v ) 
(1?enoterbiuSline a P P ' ' e d l 0 C a H y b y microelectrophoresis restored the depressed unit responsiveness after 
An example of a neuromodulator action is demonstrated in Fig. 1. In the lateral genicu-
late body of rats spontaneously active neurones responded with an activation to visual stim-
ulation. This neuronal response was markedly depressed after systemic administration of 
phenobarbital. Local application by microelectrophoresis (microiontophoresis) of acetyl-
choline restored single unit responsiveness to visual stimulation (Steiner 1968). 
A similar effect of acetylcholine was observed on a hippocampal cell (Fig. 2), which was 
also acetylcholine sensitive, but did not respond to visual stimulation. Extracellular acetyl-
choline deposition by microelectrophoresis resulted in evoked unit discharges in response 
to visual stimulation (Steiner 1968). 
Another example: In the hypothalamus of anaesthetized rats dexamethasone and corti-
costerone applied locally by microelectrophoresis inhibited the spontaneous discharge rate 
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0.5mV 
1 sec 
Fig. 2. Response of a hippocampal neurone to 
visual stimulation. 
{A) Control (without effect). 
(B) During acetylcholine microelectrophoresis the 
cell is activated by visual stimulation. 
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Fig. 3. Pulse rate histograms. The spontaneous discharge rate of a hypo-
thalamic neurone (arcuate nucleus) is inhibited by microelectrophoretically 
applied dexamethasone-phosphate (A) and corticosterone-phosphate (S). Hor-
izontal bars indicate duration of drug application. 
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(Fig. 3). The steroid sensitive cells were also sensitive to ACTH applied microelectrophore-
tically (Fig. 4) and showed an increase of the discharge rate under the drug application (Steiner 
et al. 1969). These neurones could play a role in the feedback control of corticotropin 
releasing factor (CRF) and ACTH secretion. These hormone effects could be interpreted as 
a neuromodulator action (Steiner 1971). 
Neuromodulators may be of far greater physiological significance than has hitherto been 
thought, and include classes of substances which have not been previously been suspected 
of exerting neuronal effects. For instance, it has recently been found that hypothalamic releas-
ing hormones, such as TRF and LRF, not only function as peptidergic messengers to the 
anterior pituitary gland (Schally et al. 1973, Blackwell and Guillemin 1973) but also influence 
neurones within the brain. TRF, applied by microelectrophoresis, inhibited some of sponta-
neously active hypothalamic neurones. On the other side these TRF-sensitive neurones were 
activated by triiodothyronine (T3) and L-thyroxine (T4). These results are an example of a 
possible feedback loop in neuroendocrine control (Steiner 1973). 
The diagnostic administration of TRF is commonly followed by various subjective sen-
sations (Almqvist 1972) and it has been recommended as a therapeutic agent in certain cases 
of depression (Kastin et al. 1972, Prange et al. 1972, van der Vis-Melsen and Wiener 1972). 
LRF, on the other hand, has been shown to induce mating behaviour in rodents (Moss 
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Fig. 4. Pulse rate histogram. The spontaneous discharge rate of a steroid sensitive septal neurone is activated 
by microelectrophoretically applied synthetic ACTH (tetracosactide). 
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and McCann 1973). It is possible that these neurohormones act as true neurotransmitters 
by making synaptic contact with neurones in the immediate vicinity of their site of production, 
but it is more likely that they exhibit a more widespread effect in the sense of neuromodula-
tors. Only further research will establish whether these substances are capable of exerting both 
functions or, conversely, whether bona fide transmitters may act as true neuromodulators. 
If this versatility of function proved to be the case, the definition of the substance as a neuro-
transmitter or as a neuromodulator will only hold for rigorously defined systems. 
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